Funding Challenges in Antimicrobial Resistance

This chapter explores the funding hurdles for Antimicrobial Resistance initiatives due to cuts by the US and UK governments, focusing particularly on the implications of halting support for the Fleming Fund. It emphasizes the need for coordinated global efforts, innovative solutions like a subscription model for new antibiotics, and the critical role of AI in advancing AMR strategies.